This site is intended for healthcare professionals

Phase III results show antiviral treatment favipiravir demonstrated a 28.6% faster viral clearance of Covid-19 compared to placebo. - Glenmark Pharma

Read time: 1 mins
Last updated:27th Jul 2020
Published:26th Jul 2020
Condition: Coronavirus/COVID-19 Infection
Type: drug
Register free for full access to